Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Exp Neurol. 2016 Apr 9;280:89–96. doi: 10.1016/j.expneurol.2016.04.010

Figure 1.

Figure 1

Percent mice with seizures (Racine scale, stages 3 to 5) in antagonist-treated mice. TMEV-infected C57BL/6J mice were treated with MK 801, GYKI-52466 and NBQX or with phosphate-buffered saline (PBS) as a control (treatment: day 2.5–10.5 post infection). Mice were monitored for seizures through day 21 post infection. Mice were observed for 2 hours each day immediately following the first injection of antagonist of the day. The number of mice in each group is given as N above each column. The percentage of mice with seizures was calculated as follows: (number of mice with seizures/total number of mice infected) × 100. **p<0.001, chi-square test.